Study will demonstrate the safety of a new formulation of Nutropin Liquid GH in the treatment of growth retardation in naive children with GH deficiency. Liquid GH will be given as a daily subcutaneous injection with follow-up visits scheduled at 3-month intervals for 24 mos to determine changes in height velocity. This study was part of a multi- center trial. Growth velocity increased as much as with the former formulation of Nutropin. We will continue to follow this regimen in the future.
Showing the most recent 10 out of 674 publications